Navigation Links
Genyous Biomed Announces Private Placement Financing
Date:1/29/2009

Company will leverage multivalent drug development platform, expand oncology pipeline, and explore potential for other chronic diseases

REDWOOD SHORES, Calif., Jan. 29 /PRNewswire/ -- Genyous Biomed International Inc. ("Genyous") announced today that it has entered into a $36 million private placement agreement with multiple closings. Under the terms of this financing, investments will be made in three tranches: $12 million before March 31, 2009, $12 million before December 31, 2009 and $12 million before December 31, 2010. Genyous anticipates that these funds will cover operations for three years. "This financing will enable us to further develop our oncology pipeline," said James Dao, Chairman & CEO of Genyous. "In addition, we will be able to leverage our MFMT(TM) drug development platform and extend into other chronic diseases of interest which include BPH, COPD, pain and CNS," said Mr. Dao.

MFMT(TM) drugs, a Genyous innovation, possess multiple therapeutic functions and act upon multiple biological targets to treat complex chronic diseases. These multivalent therapies were designed using a systems biology strategy that takes into consideration crosstalk between cells, their microenvironment and the host organism (e.g. the immune system response). The comprehensive therapeutic activity profile of MFMT(TM) drugs represents an opportunity to significantly improve outcomes. By possessing multiple therapeutic functions and working through a multiplicity of biological targets, relatively low and well-tolerated doses of therapeutic actives are sufficient to treat diseases while minimizing disruption of and restoring the body's homeostasis. This unique characteristic of MFMT(TM) drug candidates leads to less risk of toxicity, side effects and development of drug resistance.

Chronic diseases are now at the center of America's healthcare crisis. According to the U.S. Centers for Disease Control and Pr
'/>"/>

SOURCE Genyous Biomed International Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2

Related medicine news :

1. Environmental Tectonics Corporations BioMedical Division Announces Additional Sales of Hyperbaric Monoplace Chambers
2. USC awarded $22.2M NIH national biomedical informatics infrastructure coordinating center contract
3. BioMed Realty Trusts Center for Life Science Boston Now 91% Leased
4. BioMed Realty Trust Announces Tax Treatment of 2008 Distributions
5. Alpine Biomed Acquires Stellate to Create New Leader in Neurology Diagnostics Market
6. BioMedical Enterprises, Inc. (BME) Announces the Appointment of Kenneth I. Moch as President and Chief Executive Officer
7. Collexis BiomedExperts Hits 80,000 Registered Users Within the First Year!
8. 5,000 Medical Leaders Report Latest Advancements in Biomedical Technologies; Breakthroughs by 2015 Predicted for Alzheimer's, Heart Disease, Cancer, and Diabetes
9. Stem Cells Poised to Grow Organs for Transplant : Zannos Grekos, MD Presents Clinical Data of Research with Adult Stem Cells to Physicians at International Regenerative Biomedicine Conference
10. Response Biomedical Corporation Announces Change of Executives
11. AutismActionPlan.org Launches Doctor-Driven Biomedical Autism Treatment Website
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/28/2014)... Albany, New York (PRWEB) August 28, 2014 ... is currently perceived with great interest among other healthcare ... due to the high demand in vaccine with respect ... also highly in demand due to an improved understanding ... individuals across the United States. It has led to ...
(Date:8/28/2014)... After more than two years of ... excited to announce the opening of Houston’s Mirror Mirror ... city, Mirror Mirror Beauty Boutique offers premium aesthetic services ... corner of Richmond and Drexel near Highland Village, Mirror ... cutting-edge technology in a private, easy to access location. ...
(Date:8/28/2014)... Steven Reinberg HealthDay ... Treating pre-cancerous skin spots with a type of light therapy ... the lesions with liquid nitrogen, a new study suggests. ... the scalp and face of people with fair complexions who,ve ... of prior research found that people who underwent the light ...
(Date:8/28/2014)... August 28, 2014 Genetic testing ... throughout the world, with large reference laboratories as ... laboratories differ with regard to the genetic variants ... payers may struggle to find the most appropriate ... help clients sort through these differences, Hayes, Inc. ...
(Date:8/28/2014)... Hastings and Hastings, a Phoenix Arizona accident lawyer ... industry is pleased to report having saved a client ... This is exciting news for existing clients and prospective ... proof that Hastings and Hastings stands behind its claim ... clients money when it comes to settlements and recoveries ...
Breaking Medicine News(10 mins):Health News:U.S. Vaccine Market: Opportunities and Threats by Transparency Market Research 2Health News:U.S. Vaccine Market: Opportunities and Threats by Transparency Market Research 3Health News:Mirror Mirror Beauty Boutique to Welcome Its First Patients 2Health News: Light Therapy a Good Option for Pre-Cancerous Skin Lesions, Study Says 2Health News: Light Therapy a Good Option for Pre-Cancerous Skin Lesions, Study Says 3Health News:Hayes, Inc. Unveils Laboratory Comparison Tables for GTE Clients 2Health News:Hastings and Hastings Is Pleased To Report Having Saved A Client $13,750 On A Settlement Of $125,000 2Health News:Hastings and Hastings Is Pleased To Report Having Saved A Client $13,750 On A Settlement Of $125,000 3
... MARCH 17, 2009 The medical costs that businesses pay ... cover the costs for nearly a dozen healthy, full-term infants, ... , The average medical cost for healthy full-term babies from ... of which more than $3,800 is paid for by health ...
... 17 JumpStart Inc. , the ... of high growth early-stage businesses, and Case Technology ... technology validation fund at Case Western Reserve University ... Neuros Medical, Inc. , a Cleveland, OH company ...
... Research Group, Inc. has been covering the biologics market ... series which are syndicated primary research reports ... and Rheumatologists. The company is now expanding these ... reports which aim to compare self-reported treatment patterns ...
... device in Mexico for Minimally Invasive Treatment for ... from elite urologistsCHARLOTTE, N.C., March 16 Mexico ... and international entities of USHIFU, a global leader ... intensity focused ultrasound (HIFU) technologies, will host the ...
... Scientific, Inc. (Nasdaq: STSI ) filed its ... and Exchange Commission. The company reported 2008 net sales ... sales for 2007. However, volume sales of the company,s ... 7.8% in 2008 compared to 2007. The wholesale price ...
... /PRNewswire-Asia-FirstCall/ -- BMP,Sunstone Corporation (Nasdaq: BJGP ) ... Company is calling its $12.4 million of 10.0% Secured,Promissory ... In addition, the,Company announced the completion of the following ... million in principal amount 10.0% senior secured, ...
Cached Medicine News:Health News:Medical costs for one premature baby could cover a dozen healthy births 2Health News:Medical costs for one premature baby could cover a dozen healthy births 3Health News:JumpStart and Case Technology Ventures Invest in Neuros Medical 2Health News:JumpStart and Case Technology Ventures Invest in Neuros Medical 3Health News:JumpStart and Case Technology Ventures Invest in Neuros Medical 4Health News:JumpStart and Case Technology Ventures Invest in Neuros Medical 5Health News:BioTrends Prepares to Field ChartTrends(TM) Reports to Cover the Use of Biologic Agents in Psoriasis and Rheumatoid Arthritis 2Health News:High Intensity Focused Ultrasound Physician Training Seminar in Mexico City 2Health News:Star Scientific Files Annual Financial Report 2Health News:Star Scientific Files Annual Financial Report 3Health News:Star Scientific Files Annual Financial Report 4Health News:BMP Sunstone Exchanges and Calls Outstanding Notes Due May 2009 2
(Date:8/28/2014)... VIEJO , Kalifornien, 28. August ... hat heute den Start der Patientenrekrutierung ... Device Exemption, Forschungsausnahmegenehmigung) zur Beurteilung der ... zur Embolisation von Aneurysmen („WEB") bekanntgegeben. Adam ... of Tennessee, Department of Neurosurgery/Semmes-Murphey Clinic, ...
(Date:8/28/2014)... , Aug. 28, 2014 The ... entered a partnership to advance an experimental cancer ... (SMM), an asymptomatic stage of myeloma. ... (TAP), through which LLS forges collaborations with biotechnology ... OncoPep is developing a vaccine, ...
(Date:8/28/2014)... 2014  STAAR Surgical Company (NASDAQ: STAA ) ... delivery systems for the eye, today announced that management will ... New York Palace Hotel on Wednesday, September 3 at 7:15 ... President and CEO will offer a general overview of the ... be joined by Steve Brown , CFO, and ...
Breaking Medicine Technology:Sequent Medical kündigt Start einer IDE-Studie für das WEB System zur Embolisation von Aneurysmen bekannt 2Sequent Medical kündigt Start einer IDE-Studie für das WEB System zur Embolisation von Aneurysmen bekannt 3The Leukemia & Lymphoma Society Provides Equity Financing to OncoPep to Support Clinical Trial for Myeloma Vaccine 2STAAR Surgical To Present At The Baird 2014 Health Care Conference 2
... turned in nearly 5,500 pounds of prescription and over-the-counter ... offices throughout the state during the Drug Take Back ... amount dropped off at 38 sites last year. As ... National Association of Drug Diversion Investigators (NADDI) and ...
... 1, 2011 Vikes, Dance Fever, French Fries. The names ... your kids have heard of them. These are the street ... using them to get high. To view ... http://multivu.prnewswire.com/mnr/besmartbewell/50821/ (Logo: http://photos.prnewswire.com/prnh/20110901/MM60576LOGO ) ...
Cached Medicine Technology:NADDI and the C.A.R.E.S. Alliance Co-Sponsor Successful Drug Take Back Day 2Is Your Teen Getting High on Your Prescription? 2Is Your Teen Getting High on Your Prescription? 3
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
Medicine Products: